These vaccines have saved innumerable lives and contributed to partial control of the COVID-19 pandemic. Most of the vaccines approved for clinical use exhibit satisfactory initial protection rates against corresponding strains. However, vaccine protection declines over time, with almost all vaccines ...
BEYONDHundreds of vaccines have been developed worldwide for Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),the cause of Coronavirus disease 2019(COVID-19),since the beginning of the pandemic.These vaccines have saved innumerable lives and contributed to partial control of the COVID-...
The year in pharma for COVID-19 and beyond. Not surprisingly,COVID-19vaccines and antiviral treatments dominated headlines in 2021. But in addition to these breakthroughs, pharmaceutical and biotech companies continued to work on new technologies to treat other diseases. A cover story inChemical &...
Sinovac expects to strengthen its cooperation with BRICS countries and beyond, and will continue to provide vaccine products, jointly enhance the R&D and production capacity of vaccines and improve the capability of infectious disease prevention and control, Meng said. Since the beginning of the COVI...
Look, we’re with you—we can’t wait for to get back to exploring the world. That being said: the return to “normal” is going to be a slow process. As the vaccines roll out, we—along with many scientists, medical professionals and other experts—are optimistic that things will sta...
The public may lack confidence in vaccines developed using the messenger RNA (mRNA) technology over the traditional inactivated virus and recombinant protein platforms. The COVID-19 vaccines are being developed and produced by different manufacturers around the world. The country of manufacture of the...
摘要: Almost every aspect of the COVID-19 response, from vaccines, diagnostics, and therapeutics to medical equipment, tracking systems, software, and other innovatio关键词:COVID-19 innovation policy vaccines FDA DOI: 10.2139/ssrn.3889894
and coercion in those who benefit least—young, healthy Americans—is at the heart. It is important to consider the history of COVID-19 vaccines to identify where we succeeded and where we failed, and the effects that these errors may have more broadly on vaccination hesitancy and routine chi...
Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is
Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and are reporting positive results. In this Pro...